Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lactoferrin expression in human breast cancer.

S Penco1, M A Caligo, G Cipollini

  • 1Department of Oncology Biology and Genetics, University of Genova, Italy.

Cancer Biochemistry Biophysics
|March 30, 2000
PubMed
Summary

Lactoferrin expression is frequently lost in breast cancer, unrelated to clinical factors. Estrogen receptor and DNA methylation do not explain this loss, suggesting other regulatory mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

A Healthy Conversation Skills intervention to support changes to physical activity and dietary behaviours in community-dwelling older adults during the COVID-19 pandemic.

Perspectives in public health·2024
Same author

Work and Retirement Among Women: The Health and Employment After Fifty Study.

Occupational medicine (Oxford, England)·2024
Same author

When to suspect infantile hypercalcemia-1?

Journal of endocrinological investigation·2024
Same author

Clinical and molecular characteristics of two Italian kindreds with hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome.

Journal of endocrinological investigation·2023

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Lactoferrin, an iron-binding glycoprotein, has demonstrated anti-cancer properties in various studies.
  • Its expression patterns and regulatory mechanisms in sporadic breast cancer remain incompletely understood.

Purpose of the Study:

  • To investigate lactoferrin expression in sporadic breast cancer tissues.
  • To explore potential correlations between lactoferrin expression and clinical parameters.
  • To elucidate the molecular mechanisms underlying absent lactoferrin expression.

Main Methods:

  • Analysis of lactoferrin mRNA and protein expression in 78 breast cancer samples.
  • Immunohistochemical localization of lactoferrin protein.
  • Correlation analysis with clinical parameters.
  • Investigation of estrogen receptor expression, DNA methylation, and lactoferrin promoter mutations.

Main Results:

  • Lactoferrin expression was absent in 31 out of 78 (40%) breast cancer samples at both mRNA and protein levels.
  • No significant correlation was found between lactoferrin expression and clinical parameters.
  • An inverse correlation between estrogen receptor (ER) expression and lactoferrin expression was observed (P < 0.0001).
  • DNA methylation levels did not explain the absence of lactoferrin expression.
  • A single polymorphic site was identified in the lactoferrin promoter region.

Conclusions:

  • Lactoferrin expression is frequently downregulated or lost in sporadic breast cancer.
  • Estrogen receptor regulation is not the primary driver of lactoferrin loss.
  • Neither DNA methylation nor identified promoter mutations fully account for the absence of lactoferrin expression, indicating other regulatory pathways are involved.

Related Experiment Videos